Top Markets
Coin of the day
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

8049
Rang in Aktien #19271
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the... Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
Aktienkurs
$0.29998701
Marktkapitalisierung
$168.04M
Veränderung (1 Tag)
0.21%
Veränderung (1 Jahr)
10.81%
Land
CN
Handel Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049)

Kategorie

Dividendenhistorie für Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049)
Jilin Province Huinan Changlong Bio-pharmacy Company Limited (Aktienkürzel: 8049) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber